This 2023 study by Vezzoli et al. investigates the efficacy of combining calcium disodium EDTA (CaNa₂EDTA) chelation therapy with antioxidant micronutrient supplementation in patients with multiple sclerosis (MS). The research involved 20 MS patients and 20 healthy controls, assessing oxidative stress markers, inflammatory cytokines, and nitric oxide metabolites. Post-treatment results
